Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharma products? Contact one of our trusted professionals today.

Call (800) 521-5340

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharma Holdings, Inc. or its affiliates.

Dexamethasone Elixir, USP

Dexamethasone Elixir, USP

Compare to: Dexamethasone Elixir
Strength: 0.5mg/5mL
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.
  • Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance).
    • Congenital adrenal hyperplasia
    • Nonsuppurative thyroiditis
    • Hypercalcemia associated with cancer
  • Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:
    • Psoriatic arthritis
    • Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)
    • Ankylosing spondylitis
    • Acute and subacute bursitis
    • Acute nonspecific tenosynovitis
    • Acute gouty arthritis
    • Post-traumatic osteoarthritis
    • Synovitis of osteoarthritis
    • Epicondylitis
  • Collagen Diseases: During an exacerbation or as maintenance therapy in selected cases of:
    • Systemic lupus erythematosus
    • Acute rheumatic carditis
  • Dermatologic Diseases:
    • Pemphigus
    • Bullous dermatitis herpetiformis
    • Severe erythema multiforme (Stevens-Johnson syndrome)
    • Exfoliative dermatitis
    • Mycosis fungoides
    • Severe psoriasis
    • Severe seborrheic dermatitis
  • Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment:
    • Seasonal or perennial allergic rhinitis
    • Bronchial asthma
    • Contact dermatitis
    • Atopic dermatitis
    • Serum sickness
    • Drug hypersensitivity reactions
  • Ophthalmic Diseases: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
    • Allergic conjunctivitis
    • Keratitis
    • Allergic corneal marginal ulcers
    • Herpes zoster ophthalmicus
    • Iritis and iridocyclitis
    • Chorioretinitis
    • Anterior segment inflammation
    • Diffuse posterior uveitis and choroiditis
    • Optic neuritis
    • Sympathetic ophthalmia
  • Respiratory Diseases:
    • Symptomatic sarcoidosis
    • Loeffler's syndrome not manageable by other means
    • Berylliosis
    • Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy
    • Aspiration pneumonitis
  • Hematologic Disorders:
    • Idiopathic thrombocytopenic purpura in adults
    • Secondary thrombocytopenia in adults
    • Acquired (autoimmune) hemolytic anemia
    • Erythroblastopenia (RBC anemia)
    • Congenital (erythroid) hypoplastic anemia
  • Neoplastic Diseases: For palliative management of:
    • Leukemia and lymphomas in adults
    • Acute leukemia of childhood
  • Edematous States: To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus
  • Gastrointestinal Diseases: To tide the patient over a critical period of the disease in:
    • Ulcerative colitis
    • Regional enteritis
  • Miscellaneous:
    • Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy
    • Trichinosis with neurologic or myocardial involvement
    • Diagnostic testing of adrenocortical hyperfunction.